Filing required under SEC oversight regarding West Pharmaceutical Services, which saw a reduced stake of 15.8% in Q2.
1 report, 1 independent
Updated Aug 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Filing required under SEC oversight regarding West Pharmaceutical Services, which saw a reduced stake of 15.8% in Q2.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
SEC
Slovak company
Related events
- Palo Alto Networks received a stake reduction of 3.4% during Q2, which was filed with the SEC by Washington Trust Bank.
- Omeros Corporation disclosed the acquisition of a new stake by Legal & General Group Plc via SEC filings.
- Susquehanna International Group LLP filed a 13F report with the SEC regarding its holdings, announcing a reduction of its stake in the VanEck Uranium and Nuclear ETF by 44.3% during Q2.
- Philip Morris International filed disclosures regarding its Q1 performance and holdings with the SEC.
- Bristol Myers Squibb filed with the SEC on May 28, 2026, regarding increased institutional ownership and share purchases.